The European Commission has asked the SCCS to assess the safety of Hydroxyapatite (nano). On 15-16 March 2022, the SCCS accepted this mandate and the Committee has six months to deliver its Opinion.

This content is only available to Premium Members.

Get access to all our Premium content and services.
Start your Free Trial or Discover our plans.

Already a Premium member? Sign In

Don`t copy text!